Pioglitazone: a Promising Therapeutic Tool in Sodium Taurocholate-induced Severe Acute Pancreatitis

Overview

Journal Dig Dis Sci

Specialty Gastroenterology

Date 2010 Sep 9

PMID 20824499

Citations 4

Authors

Ping Xu

Kai Xu

Jing Wang

Jin-Ping Jiang

Ling-Quan Chen

Affiliations

Soon will be listed here.

Abstract

Background: Studies suggest that peroxisome proliferator-activated receptor γ(PPARγ) ligands may represent a therapeutic option in acute pancreatitis, yet most of them have been prophylactic administrated.

Aims: To evaluate the therapeutic effect of pioglitazone in rats with severe acute pancreatitis induced by sodium taurocholate.

Methods: Severe acute pancreatitis (SAP) was induced in male Sprague-Dawley rats by the retrograde injection of 5% sodium taurocholate into the pancreatic duct. After SAP was induced, pioglitazone was injected intraperitoneally and its role on the severity of inflammatory response and pancreatic injury was investigated. Amylase activity, inflammatory cytokines production, pathological changes of pancreas, PPARγ mRNA expression, and the survival rate were examined.

Results: Treatment with pioglitazone decreased the level of amylase activity, proinflammatory factors IL-6 and TNF-α, ameliorated pancreatic histological score, and upregulated the expression of PPARγ mRNA. The survival rate in the early stage of severe acute pancreatitis was also improved.

Conclusions: Pioglitazone can be used as a therapeutic drug and relieve the damages caused by SAP, which suggests PPARγ ligand-pioglitazone offers a potent approach for the treatment of severe acute pancreatitis.

Citing Articles

Farnesoid X receptor regulates PIK/AKT/mTOR signaling pathway, lipid metabolism, and immune response in hybrid grouper.

Xu J, Yao X, Li X, Xie S, Chi S, Zhang S Fish Physiol Biochem. 2022; 48(6):1521-1538.

PMID: 36210393 DOI: 10.1007/s10695-022-01130-z.

Peroxisome proliferator-activator receptor γ and psoriasis, molecular and cellular biochemistry.

Lin X, Meng X, Song Z, Lin J Mol Cell Biochem. 2022; 477(7):1905-1920.

PMID: 35348980 DOI: 10.1007/s11010-022-04417-0.

Regulatory roles of the PI3K/Akt signaling pathway in rats with severe acute pancreatitis.

Xu P, Wang J, Yang Z, Lou X, Chen C PLoS One. 2013; 8(11):e81767.

PMID: 24312352 PMC: 3842964. DOI: 10.1371/journal.pone.0081767.

Effects of peroxisome proliferator-activated receptor-γ activation on apoptosis in rats with acute pancreatitis.

Xu P, Lou X, Chen C, Yang Z Dig Dis Sci. 2013; 58(12):3516-23.

PMID: 24185678 DOI: 10.1007/s10620-013-2842-3.

References

Chiang D, Anozie A, Fleming W, Kiroff G . Comparative study on acute pancreatitis management. ANZ J Surg. 2004; 74(4):218-21. DOI: 10.1111/j.1445-2197.2004.02958.x. View

Tanaka T, Itoh H, Doi K, Fukunaga Y, Hosoda K, Shintani M . Down regulation of peroxisome proliferator-activated receptorgamma expression by inflammatory cytokines and its reversal by thiazolidinediones. Diabetologia. 1999; 42(6):702-10. DOI: 10.1007/s001250051218. View

Cuzzocrea S, Pisano B, Dugo L, Ianaro A, Britti D, Patel N . Rosiglitazone, a ligand of the peroxisome proliferator-activated receptor-gamma, reduces acute pancreatitis induced by cerulein. Intensive Care Med. 2004; 30(5):951-6. DOI: 10.1007/s00134-004-2180-1. View

Xu P, Zhou X, Chen L, Chen J, Xie Y, Lv L . Pioglitazone attenuates the severity of sodium taurocholate-induced severe acute pancreatitis. World J Gastroenterol. 2007; 13(13):1983-8. PMC: 4146978. DOI: 10.3748/wjg.v13.i13.1983. View

Van Laethem J, Eskinazi R, Louis H, Rickaert F, Robberecht P, Deviere J . Multisystemic production of interleukin 10 limits the severity of acute pancreatitis in mice. Gut. 1998; 43(3):408-13. PMC: 1727255. DOI: 10.1136/gut.43.3.408. View

Zingarelli B, Sheehan M, Hake P, OConnor M, Denenberg A, Cook J . Peroxisome proliferator activator receptor-gamma ligands, 15-deoxy-Delta(12,14)-prostaglandin J2 and ciglitazone, reduce systemic inflammation in polymicrobial sepsis by modulation of signal transduction pathways. J Immunol. 2003; 171(12):6827-37. DOI: 10.4049/jimmunol.171.12.6827. View

Wang A, Dai X, Luu B, Conrad D . Peroxisome proliferator-activated receptor-gamma regulates airway epithelial cell activation. Am J Respir Cell Mol Biol. 2001; 24(6):688-93. DOI: 10.1165/ajrcmb.24.6.4376. View

Giri S, Rattan R, Singh A, Singh I . The 15-deoxy-delta12,14-prostaglandin J2 inhibits the inflammatory response in primary rat astrocytes via down-regulating multiple steps in phosphatidylinositol 3-kinase-Akt-NF-kappaB-p300 pathway independent of peroxisome proliferator-activated.... J Immunol. 2004; 173(8):5196-208. DOI: 10.4049/jimmunol.173.8.5196. View

Rahimian R, Masih-Khan E, Lo M, van Breemen C, McManus B, Dube G . Hepatic over-expression of peroxisome proliferator activated receptor gamma2 in the ob/ob mouse model of non-insulin dependent diabetes mellitus. Mol Cell Biochem. 2001; 224(1-2):29-37. DOI: 10.1023/a:1011927113563. View

10.

Hill M, Young M, MCCURDY C, Gimble J . Decreased expression of murine PPARgamma in adipose tissue during endotoxemia. Endocrinology. 1997; 138(7):3073-6. DOI: 10.1210/endo.138.7.5379. View

11.

Laveda R, Martinez J, Munoz C, Penalva J, Saez J, Belda G . Different profile of cytokine synthesis according to the severity of acute pancreatitis. World J Gastroenterol. 2005; 11(34):5309-13. PMC: 4622800. DOI: 10.3748/wjg.v11.i34.5309. View

12.

Hughes C, Grewal H, Gaber L, Kotb M, Mann L, Gaber A . Anti-TNFalpha therapy improves survival and ameliorates the pathophysiologic sequelae in acute pancreatitis in the rat. Am J Surg. 1996; 171(2):274-80. DOI: 10.1016/s0002-9610(97)89568-2. View

13.

de Beaux A, Fearon K . Circulating endotoxin, tumour necrosis factor-alpha, and their natural antagonists in the pathophysiology of acute pancreatitis. Scand J Gastroenterol Suppl. 1996; 219:43-6. DOI: 10.3109/00365529609104999. View

14.

Yin R, Dong Y, Li H . PPARgamma phosphorylation mediated by JNK MAPK: a potential role in macrophage-derived foam cell formation. Acta Pharmacol Sin. 2006; 27(9):1146-52. DOI: 10.1111/j.1745-7254.2006.00359.x. View

15.

Schmidt J, Rattner D, Lewandrowski K, Compton C, Mandavilli U, Knoefel W . A better model of acute pancreatitis for evaluating therapy. Ann Surg. 1992; 215(1):44-56. PMC: 1242369. DOI: 10.1097/00000658-199201000-00007. View

16.

Enomoto N, Takei Y, Hirose M, Konno A, Shibuya T, Matsuyama S . Prevention of ethanol-induced liver injury in rats by an agonist of peroxisome proliferator-activated receptor-gamma, pioglitazone. J Pharmacol Exp Ther. 2003; 306(3):846-54. DOI: 10.1124/jpet.102.047217. View

17.

Folch-Puy E, Granell S, Iovanna J, Barthet M, Closa D . Peroxisome proliferator-activated receptor gamma agonist reduces the severity of post-ERCP pancreatitis in rats. World J Gastroenterol. 2006; 12(40):6458-63. PMC: 4100635. DOI: 10.3748/wjg.v12.i40.6458. View

18.

Vamecq J, Latruffe N . Medical significance of peroxisome proliferator-activated receptors. Lancet. 1999; 354(9173):141-8. DOI: 10.1016/S0140-6736(98)10364-1. View

19.

Chen C, Xu S, Wang W, Ding Y, Yu K, Wang B . Rosiglitazone attenuates the severity of sodium taurocholate-induced acute pancreatitis and pancreatitis-associated lung injury. Arch Med Res. 2009; 40(2):79-88. DOI: 10.1016/j.arcmed.2008.11.004. View

20.

Katayama K, Wada K, Nakajima A, Mizuguchi H, Hayakawa T, Nakagawa S . A novel PPAR gamma gene therapy to control inflammation associated with inflammatory bowel disease in a murine model. Gastroenterology. 2003; 124(5):1315-24. DOI: 10.1016/s0016-5085(03)00262-2. View